New approaches to the therapy of chronic granulocytic leukemia.
D000782:Aneuploidy; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000009:adverse effects / Q000627:therapeutic use*; D002869:Chromosome Aberrations; D002904:Chromosomes, Human, 21-22 and Y; D002999:Clone Cells; D004359:Drug Therapy, Combination; D006098:Granulocytes; D006801:Humans; D007167:Immunotherapy; D007951:Leukemia, Myeloid / Q000235:genetics / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D013156:Splenectomy; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D002066:Busulfan